SL
CLBT icon

Siren LLC’s Cellebrite CLBT Stock Holding History

Siren LLC’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Hold
311,544
– – 0.09% 90
2026
Q1 		$4.29M Buy
311,544
+161,544
+108% +$2.43M 0.12% 81
2025
Q4 		$2.71M Buy
150,000
+60,000
+67% +$1.08M 0.08% 94
2025
Q3 		$1.67M Buy
90,000
+30,000
+50% +$471K 0.07% 93
2025
Q2 		$960K Buy
+60,000
New +$1.07M 0.05% 97

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Siren LLC's CLBT Position: Q2 2026 in Review

Siren LLC held its Cellebrite (CLBT) position steady in Q2 2026 at 311,544 shares worth $4.55M. The position accounts for 0.09% of the portfolio, ranked #90.

Siren LLC first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Siren LLC held 311,544 shares of Cellebrite worth $4.55M as of Q2 2026.
  • Siren LLC left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up 0.09% of Siren LLC's portfolio in Q2 2026, its #90 holding.
  • Siren LLC first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.